Monday, February 2, 2015
Igynta Names Execs
San Diego-based biotechnology developer Ignyta said today that it has named two new executives. The company said it has appointed Pratik Multani, M.D., M.S., as Chief Medical Officer and Adrian Senderowicz, M.D., as Clinical and Regulatory Strategy Officer. Multani was most recently Chief Medical Officer at Fate Therapeutics, and also served at Kalypsys, Kanisa Pharmaceuticals, Salmedix, and Biogen Idec. Senderowicz had been serving as Chief Medical Officer for Ignyta, and shifts into the Clinical and Regulatory Strategy Officer role.